Synchrony Financial, along with its subsidiaries, is a consumer financial services company in the United States. It offers credit products such as credit cards, commercial credit products, and consumer installment loans, as well as private label credit cards, co-branded cards, and consumer banking products. The company also provides deposit products including certificates of deposit, individual retirement accounts, money market accounts, savings accounts, and sweep and affinity deposits, and accepts deposits through third-party firms. Additionally, it offers debt cancellation products and healthcare payments and financing solutions under the CareCredit and Walgreens brands, and payment and financing solutions in various industries. Founded in 1932, Synchrony Financial is headquartered in Stamford, Connecticut.
Synchrony's AI push and raised outlook offset credit and inflation worries
▼
Inflation and subprime strain Inflation hit a 3-year high of 4.2%, squeezing lower-income households. With over a quarter of Synchrony's customers below 660 credit scores and delinquencies at an 18-year high, defaults could rise and spending could slow, pressuring the stock.
This is the core fundamental risk weighing on Synchrony's business and stock.
▼
Q2 revenue miss Synchrony's Q2 revenue of $4.61 billion fell short of the $4.66 billion estimate, sending shares down 1.6%. The miss shows the company isn't growing as fast as expected, which can hold the stock back.
A concrete earnings miss that directly affects investor confidence and valuation.
▲
OpenAI partnership for in-chat shopping Synchrony is working with OpenAI to let shoppers buy directly inside ChatGPT using store cards, and is talking to Anthropic and Google about similar deals. This could expand card usage and reach new customers, a long-term positive.
A new growth avenue that could boost demand for Synchrony's cards and services.
▲
Q2 EPS beat and raised 2026 outlook Synchrony beat Q2 EPS estimates by 24.5% and raised the low end of its 2026 EPS guidance to $9.25–$9.50. Loan receivables and purchase volume grew, and the company returned $950 million to shareholders, signaling financial strength.
Strong earnings and improved guidance directly support the stock price.
Q3 2026
▲2▼2
Synchrony's AI push and raised outlook offset credit and inflation worries
▼
Inflation and subprime strain Inflation hit a 3-year high of 4.2%, squeezing lower-income households. With over a quarter of Synchrony's customers below 660 credit scores and delinquencies at an 18-year high, defaults could rise and spending could slow, pressuring the stock.
This is the core fundamental risk weighing on Synchrony's business and stock.
▼
Q2 revenue miss Synchrony's Q2 revenue of $4.61 billion fell short of the $4.66 billion estimate, sending shares down 1.6%. The miss shows the company isn't growing as fast as expected, which can hold the stock back.
A concrete earnings miss that directly affects investor confidence and valuation.
▲
OpenAI partnership for in-chat shopping Synchrony is working with OpenAI to let shoppers buy directly inside ChatGPT using store cards, and is talking to Anthropic and Google about similar deals. This could expand card usage and reach new customers, a long-term positive.
A new growth avenue that could boost demand for Synchrony's cards and services.
▲
Q2 EPS beat and raised 2026 outlook Synchrony beat Q2 EPS estimates by 24.5% and raised the low end of its 2026 EPS guidance to $9.25–$9.50. Loan receivables and purchase volume grew, and the company returned $950 million to shareholders, signaling financial strength.
Strong earnings and improved guidance directly support the stock price.
News & notes movingSYF
United States
Digital Finance & Tokenization▲
Synchrony Integrates CareCredit Financing Into Vetspire Platform
Synchrony Financial is deepening CareCredit's veterinary reach by integrating its financing options directly into Vetspire's AI-enabled practice management platform, bringing payment into the clinical workflow and reducing reliance on separate payment terminals. Vetspire is used by more than 1,000 veterinary hospitals and clinics nationwide, and about 85% of its clinics are already enrolled with CareCredit, leaving the remaining 15% as an opportunity for incremental provider adoption. The companies plan to collect clinic-level performance data to quantify whether the integration improves workflow efficiency and treatment acceptance, and participating practices gain access to CareCredit's marketing resources and business intelligence support. For Synchrony, the deal extends CareCredit into the digital infrastructure surrounding healthcare payments; in the second quarter of 2026, Health & Wellness purchase volume increased 2.1% year over year, primarily on higher Pet spending, while health and wellness loan receivables rose 0.5%.
Digital Finance & Tokenization › Digital Lending & Alt-Credit Platforms ▲Technology
SYF · Demand · Positive CareCredit financing integrated into Vetspire's platform, opening the remaining 15% of 1,000+ clinics as incremental provider adoption and extending payment reach into clinical workflow
Vetspire · Demand · Positive Vetspire gains embedded CareCredit financing plus marketing resources and business intelligence for its 1,000+ veterinary hospital clients
Synchrony Financial Study Finds Trust, Not Convenience, Will Drive AI Shopping Adoption
Synchrony Financial is arguing that trust, more than convenience, will decide how quickly consumers hand more shopping tasks to AI, citing a study with Oxford Economics that found shoppers want security, transparency, control and recourse before allowing AI agents to act for them. In the 2026 AI in Commerce study, data security was important to 82% of respondents and transparency to 77%, both ahead of time savings at 58%, while 67% said they would use AI more if fraud protection were included. Consumers were most comfortable using AI for lower-risk activities such as searching, comparing prices and applying discounts, with 79% willing to let AI apply discounts, 74% loyalty rewards and 43% purchases within a preset limit, though 46% would not use AI for purchases of $5,000 or more. The company is developing tools so financing, rewards and offers remain visible and reliable when AI agents shop, while also supporting standards for fraud protection and accountability. Peers are moving in the same direction: Global Payments Inc. said in its Agentic Commerce Report that consumers expect AI to make 15% of purchases within five years, up from 9% a year ago, and American Express Company introduced its ACE Developer Kit and Agent Purchase Protection. Synchrony Financial shares have plunged 14.1% year to date compared with the industry's 12.9% decline, and the stock trades at a forward price-to-earnings ratio of 7.08 versus the industry average of 14.66, with the Zacks Consensus Estimate for 2026 earnings pegged at $9.37 per share, implying a 0.5% decline from the year-ago period.
Artificial Intelligence › Agentic AI & Autonomous Workflows Demand
Artificial Intelligence › AI Applications & Copilots ▲Demand
SYF · Technology · Neutral Synchrony cites its AI in Commerce study and is developing tools to keep financing, rewards and offers visible when AI agents shop.
AXP · Technology · Neutral American Express introduced its ACE Developer Kit and Agent Purchase Protection for AI agent commerce, a passing peer mention.
GPN · Demand · Neutral Global Payments' Agentic Commerce Report projects AI will make 15% of purchases within five years, a passing peer mention.
Synchrony Financial has announced an enterprise collaboration with OpenAI to support AI native shopping and checkout experiences across financing, rewards, and loyalty. The announcement comes as the stock has gained 9.15% over the past 30 days and 10.64% over 90 days, though it remains down 6.12% year to date. The most followed narrative on Synchrony Financial pegs fair value at $89.22, above the last close of $79.47, implying the stock is about 10.9% undervalued. Key risks include weaker loan receivables and potential disruption to partnerships with Amazon, Walmart, or PayPal.
Artificial Intelligence › AI Applications & Copilots ▲Technology
SYF · Demand · Positive Enterprise collaboration with OpenAI to enhance AI native shopping and checkout experiences likely boosts demand for Synchrony's services.
OpenAI · Demand · Positive Expanding enterprise collaboration with Synchrony Financial increases adoption of OpenAI's AI solutions in the financial sector.
Synchrony Beats Q2 Earnings Estimates, Raises 2026 EPS Outlook
Synchrony reported second-quarter 2026 adjusted earnings per share of $2.59, beating the Zacks Consensus Estimate by 24.5% and rising 3.6% year over year. Net interest income increased 1.9% to $4.6 billion, while total loan receivables grew 2.4% to $102.2 billion and purchase volume rose 8.1% to $49.8 billion. The company narrowed its 2026 EPS guidance to $9.25 to $9.50 from $9.10 to $9.50, raising the lower end. Synchrony returned $950 million to shareholders through buybacks and dividends, with $5.7 billion remaining under its repurchase authorization. Since the earnings release, the consensus estimate has shifted down 6.95%, and the stock carries a Zacks Rank of 3, indicating a hold.
Synchrony Financial announces partnership with OpenAI
Synchrony Financial, the credit card issuer for brands including Amazon, Walmart and Lowe's, announced a collaboration with OpenAI allowing the artificial intelligence company's models to power the card company's consumer portals. The partnership, which is in its early stages, is a step toward enabling Synchrony customers to have smoother online shopping experiences. Synchrony is also launching a ChatGPT plugin that lets consumers browse its marketplace deals, promotional financing and partner offers, and is deploying OpenAI's latest models internally to speed up product development. The moves come as OpenAI prepares for its massive potential initial public offering, adding pressure on the company to turn ChatGPT into a broader platform for online commerce.
Synchrony Financial Record Purchase Volume May Boost Second-Half Earnings
Synchrony Financial reported record purchase volume of $49.8 billion in the second quarter of 2026, up 8% year over year, with growth across all five sales platforms and acceleration to 11% in June. Co-branded card purchase volume jumped 23% and accounted for 52% of total purchase volume, while the company added or renewed more than 15 partners during the quarter. Management expects stronger purchase volume to overcome elevated payment rates and lift loan receivables and earnings in the second half. Peers American Express and Capital One also benefited from strong card spending, with billed business rising 9% to $455.8 billion at American Express and purchase volume up 15% to $249.2 billion at Capital One. Synchrony shares have risen 9.1% over the past year, and the stock trades at a forward price-to-earnings ratio of 7.96 times versus the industry average of 17 times, with a Zacks Rank of 3, or Hold.
Visa beats Q2 estimates while Bread Financial leads credit card sector outperformance
Visa reported second-quarter revenues of $11.63 billion, up 14.4% year on year and exceeding analyst expectations by 2.2%, alongside beats on EBITDA and EPS. Among the six credit card stocks tracked, Bread Financial posted the biggest analyst estimate beat with revenues of $993 million, up 6.9% year on year and 3.5% above consensus, while American Express was the weakest performer with revenues of $18.55 billion, up 12.8% year on year but missing estimates by 5.8%. Capital One delivered the fastest revenue growth at 25.8% to $15.83 billion, in line with expectations, and Synchrony Financial grew revenues 1.9% to $3.72 billion, slightly below estimates but with strong EPS and efficiency ratio beats. Overall, the group's revenues were in line with consensus and share prices have held steady, rising 4.2% on average since reporting.
Synchrony's CareCredit to integrate with Stripe for health and wellness providers
Synchrony announced a new partnership with Stripe that will allow health and wellness providers using Stripe to offer CareCredit financing directly within their existing payment platform. The integration, which requires no additional setup, will give more than 12 million CareCredit cardholders expanded access to use their cards at participating providers. The initial rollout includes CareCredit's standard card transactions and six-month promotional financing options. Providers will be able to activate CareCredit through their Stripe Dashboard, streamlining checkout and reducing operational complexity.
SYF · Demand · Positive Partnership expands CareCredit usage among health and wellness providers, increasing cardholder access and transaction volume.
Stripe, Inc. · Demand · Positive Integration adds CareCredit financing to Stripe's platform, enhancing value for health and wellness providers and potentially increasing transaction volume.
Novartis, GM, 3M beat Q2 estimates while Synchrony misses
Several major companies reported second-quarter 2026 results. Novartis shares rose 2.9% after posting revenues of $14.41 billion, exceeding the Zacks Consensus Estimate of $13.95 billion. General Motors gained 4.9% on earnings of $3.57 per share, beating the estimate of $3.13. 3M climbed 7.3% with earnings of $2.40 per share, above the $2.27 estimate. Synchrony Financial fell 1.6% after revenues of $4.61 billion missed the $4.66 billion estimate.
Synchrony Q2 Earnings Decline 9% as Net Income Falls to $864 Million
Synchrony Financial reported a 9% decline in second-quarter net income available to common stockholders, falling to $864 million from $946 million a year earlier. Earnings per share rose to $2.59 from $2.50, while net interest income increased to $4.61 billion from $4.52 billion. The company reaffirmed its full-year 2026 earnings per share guidance of $9.25 to $9.50 and expects ending loan receivables growth in the mid-single-digit range. Synchrony also anticipates net interest income growth, continued strength in delinquency and net charge-off performance, and average loan receivables remaining within the 4.0% to 4.5% target range. Shares rose 2.15% to $75 in pre-market trading on the New York Stock Exchange.
Synchrony Financial Poised for Q2 Earnings Beat on Higher Purchase Volumes
Synchrony Financial is expected to beat second-quarter earnings estimates when it reports on July 21, driven by higher purchase volumes and an improved net interest margin. The Zacks Consensus Estimate for the quarter stands at $2.02 per share on revenues of $4.67 billion, with the earnings figure reflecting a 19.2% year-over-year decline while revenues are seen rising 3.4%. The company has an Earnings ESP of +2.07% and a Zacks Rank of 3, a combination that historically signals a likely beat. Analysts project interest and fees on loans of $5.47 billion, up 2.6% from a year ago, and a net interest margin of 15.31% versus 14.78% a year earlier, while total purchase volumes are expected to grow 5.1% and average active accounts to increase 1.2%. Partially offsetting these positives are higher information processing and employee costs, a nearly 10% rise in RSA, and a 0.2% dip in average interest-earning assets.
Inflation Hits 3-Year High, Subprime Credit Card Lenders Face Strain
U.S. inflation surged to a 4.2% annual rate in May, the highest since April 2023, raising concerns for credit card issuers with heavy subprime exposure. Credit card debt reached a near-record $1.25 trillion in the first quarter, up 5.9% year over year, while 13.2% of accounts are now at least 90 days delinquent, an 18-year high. Lenders like Capital One Financial and Synchrony Financial, where more than a quarter of customers have credit scores below 660, are particularly vulnerable as rising prices squeeze lower-income households. Goldman Sachs data shows the bottom-earning quintile of U.S. households is now forecast to see just a 0.8% increase in 2026 disposable cash flow, down from a 3.2% estimate in January. In contrast, American Express, which serves a more affluent customer base, reported resilient spending and stable delinquencies in the first quarter.
S&P 500 Futures Fall on Higher Yields and Inflation Jitters
US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 0.8%, as investors react to higher borrowing costs and fresh inflation worries. The US 10 year Treasury yield is sitting near 4.58%, a 4 week high, while one year US inflation expectations are at 3.7% and a drop in US oil inventories is feeding concern that fuel prices may climb. Among top movers, Alibaba Group Holding jumped 11.05% after a US judge ordered a reprieve from a Pentagon lobbying ban, Nebius Group surged 10.91% after Saturn Cloud expanded its AI platform deployment on Nebius NVIDIA infrastructure, and Arista Networks rose 8.76% with traders eyeing the newly announced Q2 earnings date on August 4. On the losing side, Synchrony Financial declined 9.61%, Moderna fell 7.48% despite recent analyst price target increases and upcoming Q2 earnings, and Bending Spoons declined 7.19%. Earnings from PepsiCo and Delta Air Lines are also in focus, with PepsiCo reporting Q2 results on Thursday and Delta Air Lines reporting Q2 on Friday.
Synchrony's delinquency and charge-off rates are holding steady or improving, suggesting its lower-credit-quality customers are weathering inflation better than feared. The 30-day delinquency rate was 4.5% in the first quarter of 2026, flat with the prior quarter and year-ago period, and improved to 4.2% in May. Net charge-offs rose slightly to 5.4% in the first quarter but were down nearly a full percentage point from 6.4% a year earlier. The company recently announced a 13% dividend increase and a $6.5 billion stock repurchase program, reflecting confidence in its financial position.
StockStory highlights Synchrony and PJT as top financials picks, flags Affirm as a sell
StockStory identifies Synchrony Financial and PJT Partners as financial stocks worth investigating, while recommending investors avoid Affirm. Synchrony, which powers over 73 million active accounts with partners like Amazon and PayPal, has compounded earnings per share at 37.9% annually over the past two years and achieved a 22.2% return on equity. PJT Partners, an advisory-focused investment bank spun off from Blackstone, posted annual revenue growth of 18.7% and EPS growth of 42% over the same period. In contrast, Affirm is flagged for negative returns on capital and a 6× net-debt-to-EBITDA ratio that could force dilutive equity offerings. Synchrony trades at 8.2× forward P/E, PJT at 19×, and Affirm at 21.8×.
Synchrony Financial reported first-quarter revenues of $3.70 billion, flat year on year and 2.4% below analyst expectations, making it the slowest revenue grower among the six credit card stocks tracked. Bread Financial posted the best results with revenues of $1.02 billion, up 4.9% year on year and beating estimates by 2.3%, while American Express had the weakest performance against estimates with revenues of $17.66 billion, up 11.6% but missing by 5.1%. Mastercard and Visa both exceeded expectations, with Mastercard reporting $8.40 billion in revenues, up 15.8% and beating by 1.8%, and Visa reporting $11.23 billion, up 17.1% and beating by 4.5%, the largest beat among peers. As a group, the six credit card stocks saw revenues in line with consensus and their share prices have held steady, rising 4.7% on average since reporting.
Synchrony Financial shares drop 11% in six months despite strong long-term EPS and ROE growth
Synchrony Financial shares have fallen 11% over the past six months to $74.51, underperforming the S&P 500's 10.9% gain, partly due to softer quarterly results. The company powers over 73 million active accounts through partnerships with Amazon, PayPal, and Lowe's. Its earnings per share grew at a 21.8% compound annual rate over the last five years, outpacing 7% annualized revenue growth, while tangible book value per share rose 15.9% annually over the same period. Synchrony Financial's five-year average return on equity stands at 22.2%, well above the sector average of around 10%. The stock now trades at 7.8 times forward earnings.
Synchrony Financial Stock Falls 9.8% Year-to-Date, Underperforming the S&P 500
Synchrony Financial shares have declined 9.8% this year, underperforming the S&P 500's 9.7% gain. Over the past 52 weeks, the stock rose 22.9%, trailing the index's 25.6% return. The company reported first-quarter earnings per share of $2.27, meeting expectations, with net interest income up 3.8% year over year to $4.6 billion. Analysts hold a consensus Moderate Buy rating and a mean price target of $89.41, implying an 18.8% upside.
USA